AtriCure, Inc. (ATRC) financial statements and ratios from SEC XBRL: revenue $534.53M (TTM), net margin -2.1%, revenue growth 12.8% YoY, P/E 229.1. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $534.53M |
| Net Margin | -2.1% |
| Revenue Growth (YoY) | 12.8% |
| EPS Growth (YoY) | -238.5% |
| FCF Growth (YoY) | -2.8% |
| P/E Ratio | 229.1 |
| EV / EBITDA | 93.3 |
| Price / Book | 4.68 |
| Price / Sales | 4.24 |
| FCF Yield | 2.2% |
| DCF Value (model) | $10.38 |
| DCF Upside vs Price | -78.2% |
| Altman Z-Score | 9.08 (safe) |
| Piotroski F-Score | 7/9 |
| Sector P/E (Healthcare) | 21.6 |
ATRC overview · ATRC earnings · ATRC KPIs · ATRC investor relations · ATRC ownership · ATRC peers · ATRC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.